Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Papillomavirus 16”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01627561
What this trial is testing

Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 148
Early research (Phase 1)UnknownNCT03870113
What this trial is testing

DC Vaccines Targeting HPV16/18 E6/E7 Protein to Regress CINI/CIN2

Who this might be right for
Cervical Intraepithelial Neoplasia
Shenzhen People's Hospital 80
Large-scale testing (Phase 3)UnknownNCT04895020
What this trial is testing

Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

Who this might be right for
HPV InfectionsCervical CancerVulvar Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 1,200
Early research (Phase 1)UnknownNCT05122221
What this trial is testing

CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers

Who this might be right for
Cervical CancerAnal CancerHead and Neck Cancers
Corregene Biotechnology Co., Ltd 12
Large-scale testing (Phase 3)Study completedNCT01862874
What this trial is testing

Efficacy and Tolerability Study of V501 in Japanese Males (V501-122)

Who this might be right for
Anogenital Human Papilloma Virus InfectionCondyloma Acuminata
Merck Sharp & Dohme LLC 1,124
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07668960
What this trial is testing

Evaluation of the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of BBM-C101 Injection in Patients With Cervical High-Grade Squamous Intraepithelial Lesion(HSIL)

Who this might be right for
High-grade Squamous Intraepithelial Lesions of the Cervix Associated With Human Papillomavirus (HPV) Type 16 and/or HPV Type 18 Infection
Shanghai Mianyi Biopharmaceutical Co., Ltd. 60
Not applicableStudy completedNCT01694875
What this trial is testing

Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System

Who this might be right for
Human Papillomavirus Infection
Gen-Probe, Incorporated 2,200
Testing effectiveness (Phase 2)Looking for participantsNCT07172256
What this trial is testing

CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs

Who this might be right for
Head and Neck Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell CarcinomaNew Diagnosis Tumor+1 more
Yale University 30
Not applicableStudy completedNCT01663259
What this trial is testing

Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients

Who this might be right for
Squamous Cell Carcinoma of the OropharynxHPV
University of Michigan Rogel Cancer Center 43
Large-scale testing (Phase 3)Study completedNCT03493542
What this trial is testing

Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)

Who this might be right for
Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ
Merck Sharp & Dohme LLC 766
Testing effectiveness (Phase 2)Study completedNCT04180215
What this trial is testing

A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

Who this might be right for
HPV-Related Squamous Cell Carcinoma
Hookipa Biotech GmbH 198
Early research (Phase 1)UnknownNCT05895370
What this trial is testing

HPV-T in HPV-16 Positive Recurrent or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
BGI, China 12
Not applicableActive Not RecruitingNCT06243666
What this trial is testing

Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerPersistent Infection
Xiamen University 2,188
Not applicableActive Not RecruitingNCT05669911
What this trial is testing

Development of a Self-collection Device for Cervical Cancer Screening

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Human Papilloma Virus
Teal Health, Inc. 235
Early research (Phase 1)Study completedNCT03900572
What this trial is testing

Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine

Who this might be right for
HPV Infections
Shanghai Zerun Biotechnology Co.,Ltd 90
Post-approval studies (Phase 4)UnknownNCT05415345
What this trial is testing

Immunogenicity and Safety of Co-immunization With Cecolin and Hecolin

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Hepatitis E Virus Infection
Xiamen Innovax Biotech Co., Ltd 480
Large-scale testing (Phase 3)Study completedNCT04635423
What this trial is testing

Efficacy, Immunogenicity, and Safety Study of V503 (9-valent Human Papillomavirus [9vHPV] Vaccine) in Japanese Males (V503-064)

Who this might be right for
Warts, GenitalNeoplasms, Anal
Merck Sharp & Dohme LLC 1,059
Not applicableUnknownNCT02411019
What this trial is testing

Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Genexine, Inc. 67
Large-scale testing (Phase 3)Active Not RecruitingNCT04708041
What this trial is testing

Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 700
Testing effectiveness (Phase 2)Active Not RecruitingNCT04713046
What this trial is testing

Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers

Who this might be right for
HPV 16+ Recurrent or Metastatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Next Page